THINK! America – Weekend of May. 20, 2017 – Show #1
Topics - May 20, 2017 - Show #1. Guest: Casey Dinges, Senior Managing Director for American Society of Civil Engineers.
Topics and Guest – May 20, 2017 – Show #1
WannaCrypt ransom ware international cyber attack: National Security Agency (NSA) leaker Edward Snowden (in exile in Russia), has issued a tweet stressing how Microsoft confirmed that the cyber attack was spawned from exploits originally created by the NSA. He said that the NSA developed the flaw that brought down the computer usage at hospitals and other institutions. WanaCrypt is an extortion scheme and reportedly based on programs developed not only by the NSA but the CIA, as well. The malware was leaked to Wikileaks and now is used by hackers. Does Edward Snowden have a legit point, in pointing his finger at the NSA, or is he just trying to flatter himself?
Commencement speakers… time again for high schools, colleges and universities to graduate their seniors. They also pick their commencement keynote speakers. Who gets selected is often highly controversial, especially if the speaker is a news maker with messaging of political activism. Now, considering many Americans say they’re bombarded with politics daily, should school administrators take a break from booking any speaker with a political message? This would include Hollywood celebrities with a political message. Why/why not? Put another way, what do you want to hear in a commencement speech?
Interview: Casey Dinges, Senior Managing Director for American Society of Civil Engineers. Topic: The state of American bridges, levies and general infrastructure.
NSYS Therapeutics is a pharmaceutical company that has just received preliminary approval from the DEA for a new synthetic marijuana drug called Syndros. The DEA doesn’t approve natural cannabis, but this synthetic gets approval. Last year this pharma company gave $500,000 to Arizona for Responsible Drug policy, a group which was successful in opposing cannabis legalization. Do you find it hypocritical that INSYS is in the “pot” business with Syndros despite they opposed cannabis legalization? Or are they in the “pot” business with a synethic to offer doctors the opportunity to treat patients with Syndros so that legitimate patients (pain and nausea) can have a good safe, controlled alternative to natural cannabis?